Ældre Resultaterne af et fase- 3 forsøg har vist, at ældre patienter kan have større sandsynlighed for at få visse bivirkninger herunder ødemer og pneumoni.
Elderly Based on the results of a phase 3 study, elderly patients may be more likely to experience certain adverse reactions, including oedema and pneumonia.